IOL Chemicals And Pharmaceuticals Ltd.

₹86.74

- 0.16 (-0.18%)

04:01 pm - close price

BSE: IOLCP

NSE: IOLCP

Industry: Pharmaceuticals & Drugs

House: Trident

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 3.44Good: 5

🟡

Adjusted EPS

Bad: 3Current: 3.44Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 8.86Good: 20

❌

Current Ratio

Bad: 1Current: 1.85Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 6.13Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 4.85Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 3.44Good: 5

🟡

Adjusted EPS

Bad: 3Current: 3.44Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 8.86Good: 20

❌

Current Ratio

Bad: 1Current: 1.85Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 6.13Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 4.85Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	563.18	545.30	520.39	503.92	502.38
Expenditure+	490.66	481.10	476.04	454.40	451.27
Other Income+	7.06	7.11	8.38	7.52	7.38
Operating Profit	72.52	64.20	44.35	49.52	51.11
Interest	3.95	4.44	4.30	3.41	2.15
Depreciation and Amortization	14.45	15.69	16.34	16.43	16.82
Profit Before Tax	61.18	51.18	32.09	37.20	39.52
Tax+	15.32	13.31	9.01	9.58	9.55
Net Profit	45.86	37.87	23.08	27.62	29.97

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503
Sales	2184.02	2217.11	2132.79	2079.21
Operational Expenses+	1925.73	1991.44	1902.20	1876.91
Operating Profit	258.29	225.67	230.59	202.30
Other Income	32.04	25.61	30.07	22.41
OPM %	11.83	10.18	10.81	9.73
Depreciation and Amortisation	43.26	46.16	62.91	71.99
Interest	8.29	16.47	16.10	14.76
Profit Before Tax	224.85	188.65	181.65	137.96
Tax	57.40	48.19	47.25	34.80
Net Profit	167.67	139.14	134.43	101.07

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	-	2024.19	2068.39	2281.50	2410.74
Liabilities+	-	2024.19	2068.39	2281.50	2410.74

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	-	93.05	122.27	289.78	178.62
Cash from Investing Activity	-	-120.52	-120.00	-190.98	-154.18
Cash from Financing Activity	-	-1.64	-4.11	-92.50	46.04
Net Cash Flow	-	-29.11	-1.84	6.30	70.48
Opening Cash & Cash Equivalents	-	32.34	3.23	1.39	7.69
Closing Cash & Cash Equivalents	-	3.23	1.39	7.69	78.17

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	52.62	52.62	52.62	52.62	48.19	48.19	48.19	48.19	48.19	48.19
Public+	47.38	47.38	47.38	47.38	51.81	51.81	51.81	51.81	51.81	51.81
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	136129	125040	130002	126701	125979	128689	130003	134235	135397	126004

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 3.44Good: 5

🟡

Adjusted EPS

Bad: 3Current: 3.44Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 8.86Good: 20

❌

Current Ratio

Bad: 1Current: 1.85Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 6.13Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 4.85Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 3.44Good: 5

🟡

Adjusted EPS

Bad: 3Current: 3.44Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 8.86Good: 20

❌

Current Ratio

Bad: 1Current: 1.85Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 6.13Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 4.85Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503
Sales	2184.02	2217.11	2132.79	2079.21
Operational Expenses+	1925.73	1991.44	1902.20	1876.91
Operating Profit	258.29	225.67	230.59	202.30
Other Income	32.04	25.61	30.07	22.41
OPM %	11.83	10.18	10.81	9.73
Depreciation and Amortisation	43.26	46.16	62.91	71.99
Interest	8.29	16.47	16.10	14.76
Profit Before Tax	224.85	188.65	181.65	137.96
Tax	57.40	48.19	47.25	34.80
Net Profit	167.67	139.14	134.43	101.07

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	563.18	545.30	520.39	503.92	502.38
Expenditure+	490.66	481.10	476.04	454.40	451.27
Other Income+	7.06	7.11	8.38	7.52	7.38
Operating Profit	72.52	64.20	44.35	49.52	51.11
Interest	3.95	4.44	4.30	3.41	2.15
Depreciation and Amortization	14.45	15.69	16.34	16.43	16.82
Profit Before Tax	61.18	51.18	32.09	37.20	39.52
Tax+	15.32	13.31	9.01	9.58	9.55
Net Profit	45.86	37.87	23.08	27.62	29.97

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	-	93.05	122.27	289.78	178.62
Cash from Investing Activity	-	-120.52	-120.00	-190.98	-154.18
Cash from Financing Activity	-	-1.64	-4.11	-92.50	46.04
Net Cash Flow	-	-29.11	-1.84	6.30	70.48
Opening Cash & Cash Equivalents	-	32.34	3.23	1.39	7.69
Closing Cash & Cash Equivalents	-	3.23	1.39	7.69	78.17

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	-	2024.19	2068.39	2281.50	2410.74
Liabilities+	-	2024.19	2068.39	2281.50	2410.74

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	52.62	52.62	52.62	52.62	48.19	48.19	48.19	48.19	48.19	48.19
Public+	47.38	47.38	47.38	47.38	51.81	51.81	51.81	51.81	51.81	51.81
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	136129	125040	130002	126701	125979	128689	130003	134235	135397	126004

IOL Chemicals And Pharmaceuticals Ltd.

₹86.74

- 0.16 (-0.18%)

04:01 pm - close price

BSE: IOLCP

NSE: IOLCP

Industry: Pharmaceuticals & Drugs

House: Trident

Overview